Journal of Cancer Therapy
Vol.4 No.3(2013), Paper ID 31598, 6
pages
DOI:10.4236/jct.2013.43085
Future Directions in Metastatic Castration Resistant Prostate Cancer (mCRPC): Clinical Rationale and Use of New-Generation Hormonal Therapies
Paolo Grassi, Elena Verzoni, Rosanna Montone, Isabella Testa, Enrico Garanzini, Pamela Biondani, Sara Pusceddu, Filippo de Braud, Giuseppe Procopio
Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
Copyright © 2013 Paolo Grassi, Elena Verzoni, Rosanna Montone, Isabella Testa, Enrico Garanzini, Pamela Biondani, Sara Pusceddu, Filippo de Braud, Giuseppe Procopio et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
P. Grassi, E. Verzoni, R. Montone, I. Testa, E. Garanzini, P. Biondani, S. Pusceddu, F. Braud and G. Procopio, "Future Directions in Metastatic Castration Resistant Prostate Cancer (mCRPC): Clinical Rationale and Use of New-Generation Hormonal Therapies,"
Journal of Cancer Therapy, Vol. 4 No. 3, 2013, pp. 698-703. doi:
10.4236/jct.2013.43085.